Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Industry perspective on life-cycle management

  • In: Symposium D3: Benefit-risk planning through the product life cycle on Tuesday, 23 May 2017, 16:40-17:15
  • At: Stockholm (Sweden) (2017)
  • Type: Presentation
  • By: HEISTERBERG, Jens (Novo Nordisk, Bagsvaerd, Denmark)
  • Co-author(s): Jens Heisterberg: Novo Nordisk, Bagsvaerd, Denmark
  • Abstract:

    Once a medicine is licensed, industry efforts are focussed on securing market access and maximising the commercial value of the product in the period until the expiry of data protection and patents. However, the benefit-risk balance in the narrower, regulatory sense should not be forgotten during the life-cycle. To a large extent, post-licensing

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses